tirzepatide injection new market Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major Eli Lilly's weight loss, diabetes

Research on GLP-1 adherence shows that patients who maintain consistent weekly schedules lose 15-22% of body weight over six months, while those with irregular dosing patterns lose only 8-12%

On the other hand, the covalent coupling of the antibody to the surface would enhance its immobilization thus improving its concentration and orientation

For buyers researching Sunlight right now: the FDA comment deadline is weeks away

Twenty-one out of the 22 patients, all of whom had markedly elevated levels of pyroglutamic acid documented in urine and/or plasma, had taken APAP (only one was acute exposure to APAP)

doi: 10.1172/JCI25083 84 LuongoCDenticeMSalvatoreD

4 Diabetes and Complications, Lilly Research Laboratories, Lilly, Indianapolis, Indiana, USA